Navigation Links
Gentag, Inc. Engages US and UK Firms to Explore Strategic Options

LONDON and WASHINGTON, March 17 /PRNewswire/ -- Gentag, Inc. (Gentag) announced today that its Board of Directors has engaged VCG & Associates Inc. and Talisman Management Ltd. to assist the Company relating to the sale or license of all or parts of its IP portfolio. VCG & Associates Inc. will provide assistance relating to pharmaceutical and medical diagnostic uses on a global or specific geographic basis. Talisman Management Ltd. will evaluate all other opportunities. Gentag does not anticipate making another announcement in this regard to this matter unless its Board has approved a definitive transaction.

"Gentag has pioneered the concept of combining cell phones with MEMS, RFID and other sensors to create low cost ubiquitous cell phone-sensor networks. Cell phone-sensor networks will broadly impact healthcare, medical diagnostics, Homeland Security and other emerging markets such as 'smart' homes. Currently, the company and its partners are developing innovative low cost monitoring solutions for diabetes, prostate cancer, blood pressure and other common health conditions such as obesity that can be monitored directly by cellular telephones," stated Dr. John P. Peeters, President of Gentag. "With the global adoption of RFID cell phones by all major OEMs and the need to reduce medical costs worldwide our patented solution is creating immediate new market opportunities for the healthcare, IT, telecommunication and defense industries. We look forward to working with VCG & Associates Inc. and Talisman Management Ltd. to assist us in exploring our options and to maximize the full potential of our technology portfolio."

About Gentag, Inc. - Gentag, Inc. is a technology development company focusing on innovative, low-cost, wireless sensor network technologies based on cell phones. The company owns unique intellectual property relating to cell phone-sensor combinations and wireless sensor networks, including US patents 6,031,454, 7,109,859, 7,148,803, 7,461,972, 7,492,254 and other pending or approved US and international patents. The effective combination of cell phones with a disposable wireless sensor platform has led to a variety of diagnostic applications providing consumers, physicians, and various industries with instant access to vital information over established wireless networks, the Internet, and client-specific databases. The company is the recipient of the 2008 North American Technology Innovation Award from Frost & Sullivan.

About VCG & Associates Inc. - VCG & Associates, Inc. is an independent US strategic marketing and contract national account organization specializing in the commercialization, licensing and acquisition/disposition of pharmaceutical, biotech, and medical device products.

About Talisman Management, Ltd. - Talisman Management Ltd. is an advisory group based in London and its geographic focus is primarily on Europe and North America.

SOURCE Gentag, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. MMR Information Systems, Inc. Engages Houlihan Smith
2. Shire Engages Palio
3. Three Firms, Two Training Programs Garner Greater Baltimore Committees 2009 Bioscience Awards
4. Amylin Pharmaceuticals Confirms Receipt of Director Nomination Notices
5. Genomma Lab Reaffirms Zero Ownership Stake in the Laser Hair Removal Chains Neoskin and Depilite
6. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
7. Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares.
8. Neogen Honored by Forbes; Two Brokerage Firms Initiate Coverage
9. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
10. Senetek Affirms Strong Financial Position
11. Online Systems Engineering Master's Program Attracts Engineers from Fortune 500 Firms
Post Your Comments:
(Date:11/24/2015)... and NEW YORK , November 24, 2015 ... by Bristol-Myers Squibb in a European ... Squibb Company in which the companies will work closely ... and other areas of unmet medical need. The collaboration is ... 5, the latest LSP fund. This is the first investment ...
(Date:11/24/2015)... NEW YORK , Nov. 24, 2015 According ... today than in 2005. This is something that many doctors, ... long time. One questions remains: with fewer PSA tests being ... cancer ? Dr. David Samadi, "Despite ... cancer, the disease remains the second leading cancer cause of ...
(Date:11/23/2015)...   Ceres, Inc . (Nasdaq: CERE ), ... the fiscal year ended August 31, 2015 and provided ... --> During fiscal year 2015, Ceres ... with a better balance of yield, energy and nutrition. ... several leading crop input providers and made significant progress ...
(Date:11/23/2015)... ... 2015 , ... Shimadzu Corporation announces that it has won ... system. The award from R&D magazine recognizes Shimadzu’s Nexera UC system as one ... analytical and testing category. R&D Magazine chose the Nexera UC system because its ...
Breaking Biology Technology:
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... , Oct. 29, 2015   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... High Tech Association (MHTA) as one of only three ... the "Software – Small and Growing" category. The Tekne Awards ... who have shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):